Cargando…
Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy
According to the World Health Organization (WHO), cancer is a leading cause of death worldwide. The identification of novel targets for cancer treatment is an area of intense work that has led Bcl-2 over-expression to be proposed as one of the hallmarks of cancer and Bcl-2 inhibition as a promising...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321604/ https://www.ncbi.nlm.nih.gov/pubmed/30544835 http://dx.doi.org/10.3390/ijms19123950 |